Why the study?
Does salt intake modulate ADMA and NOx levels in hypertension, and is ADMA associated with cardiovascular events in end-stage renal disease?
Population
Patients with essential hypertension (n=24) and patients with end-stage renal disease (n=51).
Comparison
Sequential dietary intervention: low-salt diet… vs Within-subject comparison across different salt…
Design
Cohort
Follow-up
7 days per diet phase
Authors
Loading...
ADMA may link to salt sensitivity in hypertension and higher CV events in ESRD; hypothesis-generating, no practice change without trials.
Does salt intake modulate ADMA and NOx levels in hypertension, and is ADMA associated with cardiovascular events in end-stage renal disease?
ADMA acts as a modulator of salt sensitivity in hypertension and serves as a cardiovascular risk factor in patients with end-stage renal disease.
Osanai et al. (2002) studied this question.